Amiodarone is a class III antiarrhythmic agent that inhibits adrenergic stimulation by blocking
alpha and beta receptors. It prolongs action potential and refractory period in myocardial …

Amiodarone is one of the most effective antiarrhythmic drugs available and is widely
prescribed despite several potentially life-threatening side-effects. Hepatotoxicity is the most …

Background: Hepatotoxicity due to intravenous amiodarone (HIVAD) is a rare side effect with
a distinct pattern of enzyme disturbances compared to liver damage from oral amiodarone …

Amiodarone is a benzofuran class III antiarrhythmic drug used to treat a wide spectrum of
ventricular tachyarrhythmias. The parenteral formulation is prepared in polysorbate 80 …

The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Discussion Amiodarone is a commonly used antiarrhythmic. It is associated with
extracardiac side effects, including asymptomatic hepatic dysfunction in 15–40% of patients …

The authors report the case of a non-alcoholic 73-year-old man, treated for arrhythmia with
amiodarone for 2 months, and hospitalized because of jaundice and hepatomegaly. There …

Objective To describe hepatotoxicity due to amiodarone and dronedarone from the DILIN
and the US FDA's surveillance database. Methods Hepatotoxicity due to amiodarone and …

Amiodarone is a class III antiarrhythmic drug widely used for treating a number of cardiac
arrhythmias such as atrial fibrillation, both in young and elderly people. Its hepatotoxicity is …

Hepatic dysfunction, most commonly an elevation of aminotransferases, develops in 15% to
40% of patients receiving amiodarone (1). However, acute hepatitis induced by parenteral …